StonvexLoading…
StonvexStonvexStonvexCore line items from LSAK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $533.23M | $350.18M | $171.45M | $659.70M |
Operating Income | $6.37M | $2.29M | $383.00K | $-27.10M |
Net Income | $-461.00K | $-1.01M | $-4.30M | $-87.50M |
EPS (Diluted) | $-0.01 | $-0.01 | $-0.05 | $-1.14 |
Total Assets | $674.95M | $704.64M | $652.86M | $653.71M |
Total Liabilities | $403.65M | $427.99M | $386.63M | $396.28M |
Cash & Equivalents | $90.57M | $69.47M | $72.16M | $76.52M |
Free Cash Flow OCF − CapEx | $24.28M | $-9.89M | $4.94M | $-26.32M |
Shares Outstanding | 83.25M | 81.52M | 81.46M | 81.25M |